Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing factor (CRF), the principle hypothalamic regulator of the adrenocortical axis, also functions as a neurotransmitter. In this latter role, CRF causes electrophysiological activation and epileptiform activity in various brain regions. That finding, coupled with the observation that CRF mRNA is induced in endangered brain regions following necrotic insults, suggests that the peptide might contribute to necrotic neuron loss. Supporting that, a number of studies have shown that CRF antagonists decrease ischemic or excitotoxic damage to neurons. In the present report, we demonstrate the considerable neuroprotective potential of a novel and potent CRF antagonist, astressin, against kainic acid-induced excitotoxic seizures. Intracerebroventricular infusion of the peptide both 30 min before and 10 min after seizures decreased damage in some hippocampal cell fields by as much as 84%, a magnitude of protection greater than reported for other CRF antagonists against other models of necrotic neuronal injury. Administration of astressin was done against both local microinfusion (0.035 microgram) or systemic infusion (10 mg/kg body weight) of the excitotoxin; furthermore, the peptide protected even if administered only 10 min following excitotoxin exposure. This fulfills a critical prerequisite for any eventual therapeutic use of CRF antagonists, namely that they need not be administered in anticipation of a neurological insult.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion
Sapolsky, R. M. (1996) · Stress · doi:10.3109/10253899609001092 · Cited by 738
Self-citationStress exacerbates neuron loss and cytoskeletal pathology in the hippocampus
Stein-Behrens, B., Mattson, M., Chang, I., Yeh, M., & Sapolsky, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05373.1994 · Cited by 327
Self-citation
Cited by
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Sandman, C. A., Davis, E. P., Buss, C., & Glynn, L. M. (2012) · Neuroendocrinology · doi:10.1159/000327017 · Cited by 295
Brunson, K. L., Eghbal-Ahmadi, M., Bender, R., Chen, Y., & Baram, T. Z. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151224898 · Cited by 236
Prenatal Programming of Human Neurological Function
Sandman, C. A., Davis, E. P., Buss, C., & Glynn, L. M. (2011) · International Journal of Peptides · doi:10.1155/2011/837596 · Cited by 199
Metadata
- Authors
- Maecker, H., Desai, A., Dash, R., Rivier, J., Vale, W., & Sapolsky, R.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 744
- Issue
- 1
- Pages
- 166-170
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2087962469
- Cited by
- 61
- References
- 2
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. https://app.cochat.ai/papers/10.1016/s0006-8993(96)01207-3
- The paper
- Maecker, H., Desai, A., Dash, R., Rivier, J., Vale, W., & Sapolsky, R. (1997). Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Research. https://doi.org/10.1016/s0006-8993(96)01207-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.